Item 7.01 Regulation FD Disclosure.

On January 13, 2021, Kenneth L. Londoner, Chairman and Chief Executive Officer of BioSig Technologies, Inc. (the "Company"), is expected to make a presentation regarding the Company to a virtual audience at the Sidoti Winter 2021 Investor Conference at 2:30 PM ET. The slide presentation is attached hereto as Exhibit 99.1 and incorporated herein by reference. Additionally, the Company may, from time to time, to present and/or distribute to the investment community and utilize the slide presentation at various industry and other conferences. The Company undertakes no obligation to update, supplement or amend the materials attached hereto as Exhibit 99.1.

In accordance with General Instruction B.2 of Form 8-K, the information in this Item 7.01 of this Current Report on Form 8-K, including Exhibit 99.1, shall not be deemed "filed" for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Exchange Act or the Securities Act of 1933, as amended, except as shall be expressly set forth by reference in such a filing. Furthermore, the furnishing of information under Item 7.01 of this Current Report on Form 8-K is not intended to constitute a determination by the Company that the information contained herein, including the exhibits hereto, is material or that the dissemination of such information is required by Regulation FD.




Item 9.01       Financial Statements and Exhibits.



(d) Exhibits



Exhibit Number   Description

99.1               Slide Presentation of BioSig Technologies, Inc., dated January 2021
104              Cover Page Interactive Data File (formatted as Inline XBRL)

--------------------------------------------------------------------------------

© Edgar Online, source Glimpses